Investor sues Catamaran, claims company failed to negotiate with UnitedHealth for top price of acquisition

A shareholder has sued prescription benefits manager Catamaran Corp., claiming the company's directors neglected to negotiate the top price for the company after UnitedHealth Group announced it will purchase Catamaran for $12.8 billion, reported Bloomberg. Investor Barry Hintze, who filed a class-action complaint Monday in a Chicago state court, cited Catamaran's placement in Fortune magazine's list of the 100 fastest growing companies for five consecutive years as a reason for his intention to block the deal. "The company's dominant financial performance and strong growth, together with its synergistic value to UnitedHealth, establish the inadequacy of the merger consideration," Hintze said. Article